Literature DB >> 19853031

Differential susceptibility of inbred mouse strains to Burkholderia thailandensis aerosol infection.

Lisa A Morici1, Julie Heang, Tim Tate, Peter J Didier, Chad J Roy.   

Abstract

Burkholderia pseudomallei is the causative agent of melioidosis, an emerging bacterial disease that accounts for high rates of septicaemia and death in parts of Southeast Asia and Northern Australia. The closely related species Burkholderia thailandensis is considered avirulent in humans and has been used as a surrogate for B. pseudomallei in several studies. The pathogenesis of B. pseudomallei and the role of Toll-like receptors (TLRs) in host immunity to infection are not well-defined. In this study, we exposed four strains of inbred mice (BALB/c, C57BL/6, TLR4-deficient C3H/HeJ, and TLR4-competent C3H/HeN) to increasing doses of aerosolized B. thailandensis to determine strain susceptibility and the role of TLR4 during pulmonary infection. Our results indicate an increased susceptibility in the C57BL/6 and BALB/c strains, who displayed lethality, bacterial burden in organs, and pulmonary and systemic inflammation. C3H/HeJ were as resistant as C3H/HeN mice to B. thailandensis at the highest challenge dose examined, but TLR4-deficient animals exhibited a modest increase in chronic pulmonary inflammation. These results demonstrate that B. thailandensis can be used as a surrogate for experimental laboratory investigation of melioidosis in small animal models and that TLR4 may not play a prominent role during acute pneumonic melioidosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853031      PMCID: PMC7006035          DOI: 10.1016/j.micpath.2009.10.004

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  39 in total

1.  Burkholderia pseudomallei infections.

Authors:  D A Dance
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

2.  Genetic regulation of resistance to intracellular pathogens.

Authors:  E Skamene; P Gros; A Forget; P A Kongshavn; C St Charles; B A Taylor
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

3.  Control of Mycobacterium bovis BCG infection with increased inflammation in TLR4-deficient mice.

Authors:  Cécile M C Fremond; Delphine M M Nicolle; David S Torres; Valérie F J Quesniaux
Journal:  Microbes Infect       Date:  2003-10       Impact factor: 2.700

4.  Comparative study of interleukin-1beta expression by peripheral blood mononuclear cells and purified monocytes experimentally infected with Burkholderia pseudomallei and Burkholderia thailandensis.

Authors:  Sutatip Pongcharoen; Pannika Ritvirool Niumsup; Puntharee Butkhamchot
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

5.  Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis.

Authors:  Timothy Atkins; Richard Prior; Kerri Mack; Paul Russell; Michelle Nelson; Joann Prior; Jill Ellis; Petra C F Oyston; Gordon Dougan; Richard W Titball
Journal:  J Med Microbiol       Date:  2002-07       Impact factor: 2.472

6.  Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis.

Authors:  W Joost Wiersinga; Catharina W Wieland; Gerritje J W van der Windt; Anita de Boer; Sandrine Florquin; Arjen Dondorp; Nicholas P Day; Sharon J Peacock; Tom van der Poll
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

Review 7.  Immune defense against pneumonic plague.

Authors:  Stephen T Smiley
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

8.  Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei.

Authors:  Andrea Haraga; T Eoin West; Mitchell J Brittnacher; Shawn J Skerrett; Samuel I Miller
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

9.  Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model.

Authors:  Kamilla D Lettinga; Sandrine Florquin; Peter Speelman; Ruud van Ketel; Tom van der Poll; Annelies Verbon
Journal:  J Infect Dis       Date:  2002-07-24       Impact factor: 5.226

10.  Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis).

Authors:  W Joost Wiersinga; Catharina W Wieland; Mark C Dessing; Narisara Chantratita; Allen C Cheng; Direk Limmathurotsakul; Wirongrong Chierakul; Masja Leendertse; Sandrine Florquin; Alex F de Vos; Nicholas White; Arjen M Dondorp; Nicholas P Day; Sharon J Peacock; Tom van der Poll
Journal:  PLoS Med       Date:  2007-07-31       Impact factor: 11.069

View more
  17 in total

1.  A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.

Authors:  Wildaliz Nieves; Saja Asakrah; Omar Qazi; Katherine A Brown; Jonathan Kurtz; David P Aucoin; James B McLachlan; Chad J Roy; Lisa A Morici
Journal:  Vaccine       Date:  2011-08-24       Impact factor: 3.641

2.  Dictyostelium discoideum as a model system for identification of Burkholderia pseudomallei virulence factors.

Authors:  Benjamin M Hasselbring; Maharsh K Patel; Mark A Schell
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

3.  MyD88-dependent recruitment of monocytes and dendritic cells required for protection from pulmonary Burkholderia mallei infection.

Authors:  Andrew Goodyear; Ryan Troyer; Helle Bielefeldt-Ohmann; Steven Dow
Journal:  Infect Immun       Date:  2011-10-24       Impact factor: 3.441

4.  Burkholderia pseudomallei JW270 Is Lethal in the Madagascar Hissing Cockroach Infection Model and Can Be Utilized at Biosafety Level 2 to Identify Putative Virulence Factors.

Authors:  Jennifer Chua; Ethan Nguyenkhoa; Sherry Mou; Steven A Tobery; Arthur M Friedlander; David DeShazer
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

5.  Expanding the Burkholderia pseudomallei Complex with the Addition of Two Novel Species: Burkholderia mayonis sp. nov. and Burkholderia savannae sp. nov.

Authors:  Carina M Hall; Anthony L Baker; Jason W Sahl; Mark Mayo; Holger C Scholz; Mirjam Kaestli; James Schupp; Madison Martz; Erik W Settles; Joseph D Busch; Lindsay Sidak-Loftis; Astrid Thomas; Lisa Kreutzer; Enrico Georgi; Herbert P Schweizer; Jeffrey M Warner; Paul Keim; Bart J Currie; David M Wagner
Journal:  Appl Environ Microbiol       Date:  2021-10-13       Impact factor: 5.005

6.  The Type VI secretion system spike protein VgrG5 mediates membrane fusion during intercellular spread by pseudomallei group Burkholderia species.

Authors:  Isabelle J Toesca; Christopher T French; Jeff F Miller
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

7.  Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections.

Authors:  Jerod A Skyberg; MaryClare F Rollins; Jeff S Holderness; Nicole L Marlenee; Igor A Schepetkin; Andrew Goodyear; Steven W Dow; Mark A Jutila; David W Pascual
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823

8.  Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization.

Authors:  Wildaliz Nieves; Julie Heang; Saja Asakrah; Kerstin Höner zu Bentrup; Chad J Roy; Lisa A Morici
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

9.  Recovery efficiencies for Burkholderia thailandensis from various aerosol sampling media.

Authors:  Paul Dabisch; Kristin Bower; Brandi Dorsey; Loni Wronka
Journal:  Front Cell Infect Microbiol       Date:  2012-06-11       Impact factor: 5.293

10.  Post-exposure therapeutic efficacy of COX-2 inhibition against Burkholderia pseudomallei.

Authors:  Saja Asakrah; Wildaliz Nieves; Zaid Mahdi; Mallory Agard; Arnold H Zea; Chad J Roy; Lisa A Morici
Journal:  PLoS Negl Trop Dis       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.